OpenAI News·· 5 d ago
OpenAI acquires Orchestra Bio
OpenAI acquires Orchestra Bio
AI summary
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
Selection record
Threshold 60Official, first-handFirst 62Second 62
AdmittedSum of both 124 ≥ twice the threshold 120
- Source tier
- Official, first-hand; this tier's threshold is 60
- Pre-filter
- passed：OpenAI收购AI生命科学公司，AI驱动研发
- Why it was chosen
- OpenAI moves into life-sciences R&D by acquiring Orchestra Bio, showing how its business is extending from models into industry operations.
- Same event
A model scores each item twice, independently, against one written standard, out of 100. An item is admitted only when the two scores add up to twice the threshold. The threshold is set per source tier.
Source: OpenAI News · openai.com